Douglas Goodin

Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans.

Silke Schmidt, Emmanuel Mignot, Stephen L Hauser, 2004, American journal of human genetics.

Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial

Ludwig Kappos, Ernst-Wilhelm Radue, Peter A Calabresi, 2014, The Lancet Neurology.